STING1 and Obesity: Recent research revealed that STING1 promotes inflammation in a variety of inflammatory diseases, including nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, kidney injury, neurodegenerative diseases, cardiovascular diseases, obesity, diabetes, and aging (Skopelja-Gardner et al., 2022; Bai and Liu, 2021; Li et al., 2023; Gulen et al., 2023; Szego et al., 2022; Gao et al., 2023b; Yan et al., 2022; Gao et al., 2023a).